REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/30/2025
Back to search
Official data from USPTO
INTERPACE PHARMA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INTERPACE PHARMA SOLUTIONS
ST13
US500000088680696Class
42
Filing
88680696
Registration
6092700
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
07/01/2025
Trademark type
Word
Nice classes
42
Filing date
11/05/2019
Registration date
06/30/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2020
Last transaction
07/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/02/2019
First use in commerce
12/02/2019
Drawing code
4
Owner type
16
Owner location
Parsippany, NJ
Examiner
LEE,REBECCA ANN
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Interpace Diagnostics, LLC
Representatives
Jeanne Hamburg NORRIS MCLAUGHLIN P.A.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific laboratory services for pharmaceutical development
Publications
History of USPTO decisions and trademark events.
28 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/08/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/23/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/22/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/21/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/21/2020
IUAF
USE AMENDMENT FILED
05/06/2020
EISU
TEAS STATEMENT OF USE RECEIVED
05/06/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2020
PUBO
PUBLISHED FOR OPPOSITION
03/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2020
ALIE
ASSIGNED TO LIE
02/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2020
DOCK
ASSIGNED TO EXAMINER
01/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2019
NWAP
NEW APPLICATION ENTERED
11/08/2019
Continuous trademark protection
Get notified about every new filing that threatens INTERPACE PHARMA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.